Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of TAS-118 Compared with S-1
jRCT2080222111Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of S-1 + leucovorin in Nonhematologic neoplasms (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoint: Pharmacokinetic parameters of TAS-118 compared with S-1.
02
Drugs
S-1 + leucovorin
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080222111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222111.